Trinity Biotech TRIB
NASDAQ TRIB
$11.01 +0.00 (+0.00%)
At close: Aug 20, 2026 · 12:07 PM UTC

Trinity Biotech (TRIB) Divestments (2010 - 2023)

Trinity Biotech (TRIB) posted Divestments of -$266000.0 for Q3 2023, down 100.57% sequentially from $46.8 million in Q4 2010.

Trinity Biotech (TRIB) Divestments (2010 - 2023) Analysis & Trends

Trinity Biotech has reported Divestments for 2 years, with the latest figure at -$266000.0 in Q3 2023.

  • Quarterly Divestments changed N/A year-over-year to -$266000.0 in Q3 2023, while the trailing twelve-month figure through Dec 2010 was $46.8 million (changed N/A YoY) and the FY2023 annual result came in at $28.2 million, changed N/A from the prior year.
  • Divestments fell to -$266000.0 in Q3 2023 per TRIB's latest filing, from $46.8 million in the prior quarter.
  • Over five years, Divestments peaked at -$266000.0 in Q3 2023 and troughed at -$266000.0 in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Abbott Laboratories 200.51 Bn 194.91 Bn 7.27 Bn -
2 Stryker 129.96 Bn 126.48 Bn 4.50 Bn -
3 Medtronic 120.18 Bn 110.96 Bn 6.41 Bn -
4 Boston Scientific 74.28 Bn 73.74 Bn 3.85 Bn -
5 Edwards Lifesciences 52.75 Bn 48.50 Bn 1.35 Bn -
6 Dexcom 34.67 Bn 32.73 Bn 830.00 Mn -
7 GE HealthCare Technologies 34.23 Bn 32.12 Bn 2.18 Bn -
8 Koninklijke Philips 26.46 Bn 23.14 Bn 4.55 Bn 153.43 Mn
9 Steris 23.30 Bn 22.82 Bn 684.20 Mn -
10 Trinity Biotech 6.82 Mn 1.68 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2023 -266,000.00
Dec 31, 2010 46.78 Mn